Executive record

Liisa Bayko

Liisa Bayko holds the CFO seat at Kalaris Therapeutics, Inc. on the record, Chief Financial Officer and Treasurer, effective July 20, 2026.

1 verified record · 1 company · current seat on the record: Kalaris Therapeutics, Inc.

Career line from the records

1

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-07-20AppointmentKalaris Therapeutics, Inc.current seat

    Kalaris Therapeutics, Inc. appoints Liisa Bayko as CFO

    Named as the incoming officer, Chief Financial Officer and Treasurer

    effective July 20, 2026 · 8-K filed July 20, 2026 · sec.gov, Item 5.02

Companies

1

Kalaris Therapeutics, Inc.KLRS

Biological Products, (No Diagnostic Substances)

This page lists only verified filing records that name Liisa Bayko, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.